476
Participants
Start Date
March 31, 2013
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Diclofenac sodium
Topical administration of approximately 0.5g twice daily to the 25 sq cm treatment area for 60 days.
Placebo
Topical administration of approximately 0.5g twice daily to the 25 sq cm treatment area for 60 days.
Investigator Site 23, Fremont
Investigator Site 9, Long Beach
Investigator Site 12, Newport Beach
Investigator Site 2, San Diego
Investigator Site 24, San Ramon
Investigator Site 14, Denver
Investigator Site 17, Denver
Investigator Site 21, Brandon
Investigator Site 25, Dunedin
Investigator Site 20, Fort Myers
Investigator Site 15, Jacksonville
Investigator Site 16, Miami
Investigator Site 6, Ormond Beach
Investigator Site 19, Winter Park
Investigator Site 22, Atlanta
Investigator Site 11, Boise
Investigator Site 8, Arlington Heights
Investigator Site 28, Plainfield
Investigator Site 31, Louisville
Investigator Site 27, Fridley
Investigator Site 13, Bozeman
Investigator Site 26, New Bern
Investigator Site 3, Raleigh
Investigator Site 18, Wilmington
Investigator Site 30, Cincinnati
Investigator Site 1, Hazleton
Investigator Site 5, Clinton
Investigator Site 4, Johnson City
Investigator Site 10, Nashville
Investigator Site 7, West Jordan
Investigator Site 29, Midlothian
Lead Sponsor
Actavis Inc.
INDUSTRY